{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:32:13Z","timestamp":1769610733703,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,7,21]]},"DOI":"10.1038\/onc.2015.437","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T11:03:41Z","timestamp":1448276621000},"page":"3880-3886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["KrasG12D induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells"],"prefix":"10.1038","volume":"35","author":[{"given":"S","family":"Diersch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Schneeweis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"J\u00f6rs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J T","family":"Siveke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Saur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A K","family":"Rustgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,23]]},"reference":[{"key":"BFonc2015437_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2012.07.024","volume":"22","author":"CM Ardito","year":"2012","unstructured":"Ardito CM, Gruner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK et al. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell 2012; 22: 304\u2013317.","journal-title":"Cancer Cell"},{"key":"BFonc2015437_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccr.2012.08.001","volume":"22","author":"C Navas","year":"2012","unstructured":"Navas C, Hernandez-Porras I, Schuhmacher AJ, Sibilia M, Guerra C, Barbacid M . EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. Cancer Cell 2012; 22: 318\u2013330.","journal-title":"Cancer Cell"},{"key":"BFonc2015437_CR3","doi-asserted-by":"publisher","first-page":"a020768","DOI":"10.1101\/cshperspect.a020768","volume":"6","author":"MA Lemmon","year":"2014","unstructured":"Lemmon MA, Schlessinger J, Ferguson KM . The EGFR family: not so prototypical receptor tyrosine kinases. Cold Spring Harb Perspect Biol 2014; 6: a020768.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"BFonc2015437_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/bjc.2014.215","volume":"111","author":"S Eser","year":"2014","unstructured":"Eser S, Schnieke A, Schneider G, Saur D . Oncogenic KRAS signalling in pancreatic cancer. Br J Cancer 2014; 111: 817\u2013822.","journal-title":"Br J Cancer"},{"key":"BFonc2015437_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.stem.2014.11.001","volume":"16","author":"S Puri","year":"2015","unstructured":"Puri S, Folias AE, Hebrok M . Plasticity and dedifferentiation within the pancreas: development, homeostasis, and disease. Cell Stem Cell 2015; 16: 18\u201331.","journal-title":"Cell Stem Cell"},{"key":"BFonc2015437_CR6","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1172\/JCI57131","volume":"121","author":"M Reichert","year":"2011","unstructured":"Reichert M, Rustgi AK . Pancreatic ductal cells in development, regeneration, and neoplasia. J Clin Invest 2011; 121: 4572\u20134578.","journal-title":"J Clin Invest"},{"key":"BFonc2015437_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccr.2012.10.025","volume":"22","author":"JL Kopp","year":"2012","unstructured":"Kopp JL, von Figura G, Mayes E, Liu FF, Dubois CL, Morris JP et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 22: 737\u2013750.","journal-title":"Cancer Cell"},{"key":"BFonc2015437_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","volume":"21","author":"Y Pylayeva-Gupta","year":"2012","unstructured":"Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D . Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012; 21: 836\u2013847.","journal-title":"Cancer Cell"},{"key":"BFonc2015437_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ccr.2010.10.020","volume":"18","author":"KE Lee","year":"2010","unstructured":"Lee KE, Bar-Sagi D . Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells. Cancer Cell 2010; 18: 448\u2013458.","journal-title":"Cancer Cell"},{"key":"BFonc2015437_CR10","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1073\/pnas.0701158104","volume":"104","author":"JP Morton","year":"2007","unstructured":"Morton JP, Mongeau ME, Klimstra DS, Morris JP, Lee YC, Kawaguchi Y et al. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci USA 2007; 104: 5103\u20135108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015437_CR11","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/1541-7786.MCR-12-0340-T","volume":"10","author":"VA Appleman","year":"2012","unstructured":"Appleman VA, Ahronian LG, Cai J, Klimstra DS, Lewis BC . KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK\/ERK-stimulated IGF1R signaling. Mol Cancer Res 2012; 10: 1228\u20131239.","journal-title":"Mol Cancer Res"},{"key":"BFonc2015437_CR12","doi-asserted-by":"publisher","first-page":"ra42","DOI":"10.1126\/scisignal.2005049","volume":"7","author":"W Zhang","year":"2014","unstructured":"Zhang W, Nandakumar N, Shi Y, Manzano M, Smith A, Graham G et al. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci Signal 2014; 7: ra42.","journal-title":"Sci Signal"},{"key":"BFonc2015437_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 2015; 160: 324\u2013338.","journal-title":"Cell"},{"key":"BFonc2015437_CR14","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1593\/neo.111016","volume":"13","author":"L Conradt","year":"2011","unstructured":"Conradt L, Godl K, Schaab C, Tebbe A, Eser S, Diersch S et al. Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma. Neoplasia 2011; 13: 1026\u20131034.","journal-title":"Neoplasia"},{"key":"BFonc2015437_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0092-8674(00)00026-X","volume":"102","author":"M Sibilia","year":"2000","unstructured":"Sibilia M, Fleischmann A, Behrens A, Stingl L, Carroll J, Watt FM et al. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 2000; 102: 211\u2013220.","journal-title":"Cell"},{"key":"BFonc2015437_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ccr.2012.08.019","volume":"22","author":"RM Perera","year":"2012","unstructured":"Perera RM, Bardeesy N . Ready, set, go: the EGF receptor at the pancreatic cancer starting line. Cancer Cell 2012; 22: 281\u2013282.","journal-title":"Cancer Cell"},{"key":"BFonc2015437_CR17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature07260","volume":"455","author":"L Soucek","year":"2008","unstructured":"Soucek L, Whitfield J, Martins CP, Finch AJ, Murphy DJ, Sodir NM et al. Modelling Myc inhibition as a cancer therapy. Nature 2008; 455: 679\u2013683.","journal-title":"Nature"},{"key":"BFonc2015437_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1101\/gad.205542.112","volume":"27","author":"L Soucek","year":"2013","unstructured":"Soucek L, Whitfield JR, Sodir NM, Masso-Valles D, Serrano E, Karnezis AN et al. Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev 2013; 27: 504\u2013513.","journal-title":"Genes Dev"},{"key":"BFonc2015437_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1101\/gad.232082.113","volume":"28","author":"M Saborowski","year":"2014","unstructured":"Saborowski M, Saborowski A, Morris JP, Bosbach B, Dow LE, Pelletier J et al. A modular and flexible ESC-based mouse model of pancreatic cancer. Genes Dev 2014; 28: 85\u201397.","journal-title":"Genes Dev"},{"key":"BFonc2015437_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature13473","volume":"511","author":"S Walz","year":"2014","unstructured":"Walz S, Lorenzin F, Morton J, Wiese KE, von Eyss B, Herold S et al. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature 2014; 511: 483\u2013487.","journal-title":"Nature"},{"issue":"13","key":"BFonc2015437_CR21","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2015.216","volume":"35","author":"E Hessmann","year":"2015","unstructured":"Hessmann E, Schneider G, Ellenrieder V, Siveke JT . MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies. Oncogene 2015; e-pub ahead of print 29 June 2015; doi:10.1038\/onc.2015.216.","journal-title":"Oncogene"},{"key":"BFonc2015437_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1053\/j.gastro.2008.10.015","volume":"136","author":"C Bonal","year":"2009","unstructured":"Bonal C, Thorel F, Ait-Lounis A, Reith W, Trumpp A, Herrera PL . Pancreatic inactivation of c-Myc decreases acinar mass and transdifferentiates acinar cells into adipocytes in mice. Gastroenterology 2009; 136: 309\u2013319 e309.","journal-title":"Gastroenterology"},{"key":"BFonc2015437_CR23","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1242\/dev.017137","volume":"135","author":"H Nakhai","year":"2008","unstructured":"Nakhai H, Siveke JT, Mendoza-Torres L, Schmid RM . Conditional inactivation of Myc impairs development of the exocrine pancreas. Development 2008; 135: 3191\u20133196.","journal-title":"Development"},{"key":"BFonc2015437_CR24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/mc.20569","volume":"48","author":"C Schild","year":"2009","unstructured":"Schild C, Wirth M, Reichert M, Schmid RM, Saur D, Schneider G . PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells. Mol Carcinog 2009; 48: 1149\u20131158.","journal-title":"Mol Carcinog"},{"key":"BFonc2015437_CR25","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/nm.3646","volume":"20","author":"N Sch\u00f6nhuber","year":"2014","unstructured":"Sch\u00f6nhuber N, Seidler B, Schuck K, Veltkamp C, Schachtler C, Zukowska M et al. A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. Nat Med 2014; 20: 1340\u20131347.","journal-title":"Nat Med"},{"key":"BFonc2015437_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semcancer.2006.08.004","volume":"16","author":"SR Hann","year":"2006","unstructured":"Hann SR . Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Semin Cancer Biol 2006; 16: 288\u2013302.","journal-title":"Semin Cancer Biol"},{"key":"BFonc2015437_CR27","doi-asserted-by":"publisher","first-page":"34725","DOI":"10.1074\/jbc.R600017200","volume":"281","author":"J Vervoorts","year":"2006","unstructured":"Vervoorts J, Luscher-Firzlaff J, Luscher B . The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem 2006; 281: 34725\u201334729.","journal-title":"J Biol Chem"},{"key":"BFonc2015437_CR28","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/gut.2010.225920","volume":"60","author":"AV Pinho","year":"2011","unstructured":"Pinho AV, Rooman I, Reichert M, De Medts N, Bouwens L, Rustgi AK et al. Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis. Gut 2011; 60: 958\u2013966.","journal-title":"Gut"},{"key":"BFonc2015437_CR29","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.4161\/cc.10.8.15363","volume":"10","author":"AV Pinho","year":"2011","unstructured":"Pinho AV, Rooman I, Real FX . p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle 2011; 10: 1312\u20131321.","journal-title":"Cell Cycle"},{"key":"BFonc2015437_CR30","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.devcel.2009.11.003","volume":"17","author":"M Solar","year":"2009","unstructured":"Solar M, Cardalda C, Houbracken I, Martin M, Maestro MA, De Medts N et al. Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth. Dev Cell 2009; 17: 849\u2013860.","journal-title":"Dev Cell"},{"key":"BFonc2015437_CR31","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1172\/JCI78585","volume":"125","author":"S J\u00f6rs","year":"2015","unstructured":"J\u00f6rs S, Jeliazkova P, Ringelhan M, Thalhammer J, Durl S, Ferrer J et al. Lineage fate of ductular reactions in liver injury and carcinogenesis. J Clin Invest 2015; 125: 2445\u20132457.","journal-title":"J Clin Invest"},{"key":"BFonc2015437_CR32","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1038\/sj.onc.1206641","volume":"22","author":"X Yin","year":"2003","unstructured":"Yin X, Giap C, Lazo JS, Prochownik EV . Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene 2003; 22: 6151\u20136159.","journal-title":"Oncogene"},{"key":"BFonc2015437_CR33","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/j.gastro.2004.03.058","volume":"127","author":"FS Schreiber","year":"2004","unstructured":"Schreiber FS, Deramaudt TB, Brunner TB, Boretti MI, Gooch KJ, Stoffers DA et al. Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene. Gastroenterology 2004; 127: 250\u2013260.","journal-title":"Gastroenterology"},{"key":"BFonc2015437_CR34","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1158\/1541-7786.MCR-14-0709","volume":"13","author":"J von Burstin","year":"2015","unstructured":"von Burstin J, Diersch S, Schneider G, Reichert M, Rustgi AK, Schmid RM . Detection of tumor suppressor genes in cancer development by a novel shRNA-based method. Mol Cancer Res 2015; 13: 863\u2013869.","journal-title":"Mol Cancer Res"},{"key":"BFonc2015437_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.stem.2014.06.019","volume":"15","author":"R Sancho","year":"2014","unstructured":"Sancho R, Gruber R, Gu G, Behrens A . Loss of Fbw7 reprograms adult pancreatic ductal cells into alpha, delta, and beta cells. Cell Stem Cell 2014; 15: 139\u2013153.","journal-title":"Cell Stem Cell"},{"key":"BFonc2015437_CR36","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1073\/pnas.1219592110","volume":"110","author":"I Ischenko","year":"2013","unstructured":"Ischenko I, Zhi J, Moll UM, Nemajerova A, Petrenko O . Direct reprogramming by oncogenic Ras and Myc. Proc Natl Acad Sci USA 2013; 110: 3937\u20133942.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015437_CR37","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1073\/pnas.1319911111","volume":"111","author":"I Ischenko","year":"2014","unstructured":"Ischenko I, Petrenko O, Hayman MJ . Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas. Proc Natl Acad Sci USA 2014; 111: 3466\u20133471.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015437_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1101\/gad.204453.112","volume":"27","author":"M Reichert","year":"2013","unstructured":"Reichert M, Takano S, von Burstin J, Kim SB, Lee JS, Ihida-Stansbury K et al. The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes Dev 2013; 27: 288\u2013300.","journal-title":"Genes Dev"},{"key":"BFonc2015437_CR39","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/304596a0","volume":"304","author":"H Land","year":"1983","unstructured":"Land H, Parada LF, Weinberg RA . Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983; 304: 596\u2013602.","journal-title":"Nature"},{"key":"BFonc2015437_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4161\/cc.10.1.14449","volume":"10","author":"C Wang","year":"2011","unstructured":"Wang C, Lisanti MP, Liao DJ . Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology. Cell Cycle 2011; 10: 57\u201367.","journal-title":"Cell Cycle"},{"key":"BFonc2015437_CR41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12029-011-9258-0","volume":"42","author":"A Skoudy","year":"2011","unstructured":"Skoudy A, Hernandez-Munoz I, Navarro P . Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc. J Gastrointest Cancer 2011; 42: 76\u201384.","journal-title":"J Gastrointest Cancer"},{"key":"BFonc2015437_CR42","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/nm.3952","volume":"21","author":"PK Mazur","year":"2015","unstructured":"Mazur PK, Herner A, Mello SS, Wirth M, Hausmann S, Sanchez-Rivera FJ et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nat Med 2015; 21: 1163\u20131171.","journal-title":"Nat Med"},{"key":"BFonc2015437_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.devcel.2007.06.001","volume":"13","author":"Q Zhou","year":"2007","unstructured":"Zhou Q, Law AC, Rajagopal J, Anderson WJ, Gray PA, Melton DA . A multipotent progenitor domain guides pancreatic organogenesis. Dev Cell 2007; 13: 103\u2013114.","journal-title":"Dev Cell"},{"key":"BFonc2015437_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1073\/pnas.88.1.93","volume":"88","author":"EP Sandgren","year":"1991","unstructured":"Sandgren EP, Quaife CJ, Paulovich AG, Palmiter RD, Brinster RL . Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci USA 1991; 88: 93\u201397.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015437_CR45","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/ijc.27322","volume":"131","author":"PJ Grippo","year":"2012","unstructured":"Grippo PJ, Sandgren EP . Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents. Int J Cancer 2012; 131: 1243\u20131248.","journal-title":"Int J Cancer"},{"key":"BFonc2015437_CR46","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1158\/0008-5472.CAN-12-2067","volume":"73","author":"WC Lin","year":"2013","unstructured":"Lin WC, Rajbhandari N, Liu C, Sakamoto K, Zhang Q, Triplett AA et al. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Cancer Res 2013; 73: 1821\u20131830.","journal-title":"Cancer Res"},{"key":"BFonc2015437_CR47","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1128\/MCB.13.1.320","volume":"13","author":"EP Sandgren","year":"1993","unstructured":"Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, Lee DC . Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 1993; 13: 320\u2013330.","journal-title":"Mol Cell Biol"},{"key":"BFonc2015437_CR48","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05541","volume":"445","author":"A Ventura","year":"2007","unstructured":"Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445: 661\u2013665.","journal-title":"Nature"},{"key":"BFonc2015437_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4: 437\u2013450.","journal-title":"Cancer Cell"},{"key":"BFonc2015437_CR50","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1093\/nar\/gku763","volume":"42","author":"M Wirth","year":"2014","unstructured":"Wirth M, Stojanovic N, Christian J, Paul MC, Stauber RH, Schmid RM et al. MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib. Nucleic Acids Res 2014; 42: 10433\u201310447.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2015437_CR51","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/dvg.20335","volume":"45","author":"MD Muzumdar","year":"2007","unstructured":"Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L . A global double-fluorescent Cre reporter mouse. Genesis 2007; 45: 593\u2013605.","journal-title":"Genesis"},{"key":"BFonc2015437_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1074-7613(01)00088-7","volume":"14","author":"IM de Alboran","year":"2001","unstructured":"de Alboran IM, O'Hagan RC, Gartner F, Malynn B, Davidson L, Rickert R et al. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 2001; 14: 45\u201355.","journal-title":"Immunity"},{"key":"BFonc2015437_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 2010; 13: 133\u2013140.","journal-title":"Nat Neurosci"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2015437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015437","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:12:18Z","timestamp":1647893538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2015437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,23]]},"references-count":53,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2016,7,21]]}},"alternative-id":["BFonc2015437"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.437","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,23]]},"assertion":[{"value":"13 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}